Evaxion A/s balance sheet

At the end of fiscal 2025, Evaxion A/s had total assets of $28.4m, total liabilities of $11.4m and shareholders' equity of $17.0m. It held $23.2m in cash against $5.5m of debt: net cash of $17.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Evaxion A/s: balance sheet, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	13	6	6	23
Receivables	3	2	—	—
Total current assets	17	8	9	25
Total assets	22	13	12	28
Total current liabilities	4	7	4	4
Short-term debt	0	0	0	0
Long-term debt	8	8	8	5
Total debt	8	9	8	6
Total liabilities	14	18	14	11
Shareholders' equity	8	−5	−2	17
Net debt (negative = net cash)	−5	3	2	−18

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: EVAX vs ROIV ADAG vs EVAX EVAX vs TCRX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Evaxion A/s's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Evaxion A/s.